RIBONUCLEASES FOR TREATING VIRAL INFECTIONS

This disclosure is directed to compounds and pharmaceutical compositions for treating and preventing viral diseases, as Covid-19. Among others, the invention relates to the use of immune cells and ribonucleases in the preparation and use of pharmaceutical formulations for the treatment of said disea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	SQUIQUERA, Luis, HODGE, Tom, SULLEY, Jamie, GLOZMAN, Sabina
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	SQUIQUERA, Luis HODGE, Tom SULLEY, Jamie GLOZMAN, Sabina
description	This disclosure is directed to compounds and pharmaceutical compositions for treating and preventing viral diseases, as Covid-19. Among others, the invention relates to the use of immune cells and ribonucleases in the preparation and use of pharmaceutical formulations for the treatment of said disease. La présente invention concerne des composés et des compositions pharmaceutiques destinés à traiter et prévenir des maladies virales, telles que la Covid-19. L'invention concerne en autres l'utilisation de cellules immunitaires et de ribonucléases dans la préparation et l'utilisation de formulations pharmaceutiques pour le traitement de ladite maladie.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2021188974A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2021188974A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2021188974A13</originalsourceid><addsrcrecordid>eNrjZNAO8nTy9wt19nF1DHYNVnDzD1IICXJ1DPH0c1cI8wxy9FHw9HNzdQ7x9PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGhoYWFpbmJo6GxsSpAgAf9iYa</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RIBONUCLEASES FOR TREATING VIRAL INFECTIONS</title><source>esp@cenet</source><creator>SQUIQUERA, Luis ; HODGE, Tom ; SULLEY, Jamie ; GLOZMAN, Sabina</creator><creatorcontrib>SQUIQUERA, Luis ; HODGE, Tom ; SULLEY, Jamie ; GLOZMAN, Sabina</creatorcontrib><description>This disclosure is directed to compounds and pharmaceutical compositions for treating and preventing viral diseases, as Covid-19. Among others, the invention relates to the use of immune cells and ribonucleases in the preparation and use of pharmaceutical formulations for the treatment of said disease. La présente invention concerne des composés et des compositions pharmaceutiques destinés à traiter et prévenir des maladies virales, telles que la Covid-19. L'invention concerne en autres l'utilisation de cellules immunitaires et de ribonucléases dans la préparation et l'utilisation de formulations pharmaceutiques pour le traitement de ladite maladie.</description><language>eng ; fre</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210923&DB=EPODOC&CC=WO&NR=2021188974A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210923&DB=EPODOC&CC=WO&NR=2021188974A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SQUIQUERA, Luis</creatorcontrib><creatorcontrib>HODGE, Tom</creatorcontrib><creatorcontrib>SULLEY, Jamie</creatorcontrib><creatorcontrib>GLOZMAN, Sabina</creatorcontrib><title>RIBONUCLEASES FOR TREATING VIRAL INFECTIONS</title><description>This disclosure is directed to compounds and pharmaceutical compositions for treating and preventing viral diseases, as Covid-19. Among others, the invention relates to the use of immune cells and ribonucleases in the preparation and use of pharmaceutical formulations for the treatment of said disease. La présente invention concerne des composés et des compositions pharmaceutiques destinés à traiter et prévenir des maladies virales, telles que la Covid-19. L'invention concerne en autres l'utilisation de cellules immunitaires et de ribonucléases dans la préparation et l'utilisation de formulations pharmaceutiques pour le traitement de ladite maladie.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAO8nTy9wt19nF1DHYNVnDzD1IICXJ1DPH0c1cI8wxy9FHw9HNzdQ7x9PcL5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGhoYWFpbmJo6GxsSpAgAf9iYa</recordid><startdate>20210923</startdate><enddate>20210923</enddate><creator>SQUIQUERA, Luis</creator><creator>HODGE, Tom</creator><creator>SULLEY, Jamie</creator><creator>GLOZMAN, Sabina</creator><scope>EVB</scope></search><sort><creationdate>20210923</creationdate><title>RIBONUCLEASES FOR TREATING VIRAL INFECTIONS</title><author>SQUIQUERA, Luis ; HODGE, Tom ; SULLEY, Jamie ; GLOZMAN, Sabina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2021188974A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2021</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SQUIQUERA, Luis</creatorcontrib><creatorcontrib>HODGE, Tom</creatorcontrib><creatorcontrib>SULLEY, Jamie</creatorcontrib><creatorcontrib>GLOZMAN, Sabina</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SQUIQUERA, Luis</au><au>HODGE, Tom</au><au>SULLEY, Jamie</au><au>GLOZMAN, Sabina</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RIBONUCLEASES FOR TREATING VIRAL INFECTIONS</title><date>2021-09-23</date><risdate>2021</risdate><abstract>This disclosure is directed to compounds and pharmaceutical compositions for treating and preventing viral diseases, as Covid-19. Among others, the invention relates to the use of immune cells and ribonucleases in the preparation and use of pharmaceutical formulations for the treatment of said disease. La présente invention concerne des composés et des compositions pharmaceutiques destinés à traiter et prévenir des maladies virales, telles que la Covid-19. L'invention concerne en autres l'utilisation de cellules immunitaires et de ribonucléases dans la préparation et l'utilisation de formulations pharmaceutiques pour le traitement de ladite maladie.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng ; fre
recordid	cdi_epo_espacenet_WO2021188974A1
source	esp@cenet
subjects	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
title	RIBONUCLEASES FOR TREATING VIRAL INFECTIONS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T03%3A51%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SQUIQUERA,%20Luis&rft.date=2021-09-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2021188974A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true